Route 92 Medical announced today that it settled the patent litigation filed against Q’Apel Medical over delivery catheter intellectual property. San Mateo, California–based Route 92 develops a suite of reperfusion and access systems leveraging the patented Tenzing delivery catheter. The products aim to improve the efficiency of endovascular … [Read more...] about Route 92 Medical settles patent spat with Q’Apel
Q'Apel Medical
FDA says Q’Apel aspiration system recall is Class I following discontinuation
Q’Apel Medical announced that the FDA classified a voluntary recall of its 072 Aspiration System as Class I, the most serious kind. The company earlier this year initiated a discontinuation and recall of the system, also known as "Hippo," which includes "Cheetah." It recalled 1,617 units of the Hippo system after receiving an FDA warning letter. … [Read more...] about FDA says Q’Apel aspiration system recall is Class I following discontinuation
Q’Apel Medical launches Armadillo radial access catheter
Q'Apel Medical today announced that its Armadillo radial access system won FDA 510(k) clearance. Fremont, Calif.-based Q'Apel Medical designed the Armadillo to help physicians move from femoral artery access to radial artery access. The company's radial platform of access catheters is specifically designed to address challenges associated with … [Read more...] about Q’Apel Medical launches Armadillo radial access catheter
